Lombard Odier Asset Management (Switzerland)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.2M Buy
36,080
+4,423
+14% +$4.48M 1.26% 11
2025
Q4
$34M Buy
31,657
+4,992
+19% +$4.77M 1.45% 10
2025
Q3
$20.3M Sell
26,665
-738
-3% -$549K 0.92% 14
2025
Q2
$21.4M Buy
27,403
+1,096
+4% +$852K 1.08% 14
2025
Q1
$21.7M Buy
26,307
+3,804
+17% +$3.17M 1.25% 13
2024
Q4
$17.4M Buy
22,503
+1,189
+6% +$984K 1.29% 10
2024
Q3
$18.9M Buy
21,314
+2,248
+12% +$2.02M 1.58% 8
2024
Q2
$17.3M Sell
19,066
-17,035
-47% -$13.6M 1.76% 8
2024
Q1
$28.1M Buy
36,101
+9,873
+38% +$7.03M 1.98% 6
2023
Q4
$15.3M Sell
26,228
-3,524
-12% -$2.06M 2.05% 10
2023
Q3
$16M Sell
29,752
-6,138
-17% -$3.16M 2.58% 8
2023
Q2
$16.8M Sell
35,890
-9,536
-21% -$4M 2.39% 11
2023
Q1
$15.6M Buy
45,426
+16,903
+59% +$5.7M 1.36% 18
2022
Q4
$10.4M Buy
28,523
+24,806
+667% +$8.8M 0.83% 41
2022
Q3
$1.2M Sell
3,717
-251
-6% -$79.5K 0.1% 144
2022
Q2
$1.29M Buy
+3,968
New +$1.19M 0.11% 135
2022
Q1
Sell
-4,546
Closed -$1.26M 290
2021
Q4
$1.26M Buy
+4,546
New +$1.15M 0.08% 124
2021
Q3
Sell
-4,941
Closed -$1.13M 366
2021
Q2
$1.13M Buy
4,941
+1,208
+32% +$243K 0.06% 184
2021
Q1
$697K Buy
+3,733
New +$730K 0.05% 200
2020
Q4
Sell
-10,418
Closed -$1.54M 252
2020
Q3
$1.54M Buy
+10,418
New +$1.61M 0.16% 97
2020
Q2
Sell
-12,174
Closed -$1.69M 249
2020
Q1
$1.69M Sell
12,174
-6,548
-35% -$900K 0.23% 68
2019
Q4
$2.46M Buy
18,722
+5,510
+42% +$639K 0.23% 85
2019
Q3
$1.48M Sell
13,212
-13,436
-50% -$1.5M 0.16% 116
2019
Q2
$2.95M Buy
26,648
+62
+0.2% +$7.3K 0.3% 65
2019
Q1
$3.45M Sell
26,586
-109,373
-80% -$13.3M 0.35% 57
2018
Q4
$15.7M Buy
135,959
+128,674
+1,766% +$14.4M 1.79% 11
2018
Q3
$782K Buy
7,285
+3,960
+119% +$396K 0.08% 202
2018
Q2
$284K Hold
3,325
0.03% 261
2018
Q1
$257K Sell
3,325
-1,901
-36% -$153K 0.03% 322
2017
Q4
$441K Hold
5,226
0.04% 241
2017
Q3
$447K Hold
5,226
0.04% 249
2017
Q2
$430K Hold
5,226
0.05% 260
2017
Q1
$440K Buy
+5,226
New +$419K 0.05% 263
2016
Q3
Sell
-5,226
Closed -$412K 203
2016
Q2
$412K Hold
5,226
0.06% 206
2016
Q1
$376K Hold
5,226
0.04% 199
2015
Q4
$445K Sell
5,226
-9,259
-64% -$768K 0.05% 191
2015
Q3
$1.21M Buy
14,485
+2,787
+24% +$235K 0.11% 79
2015
Q2
$977K Sell
11,698
-3,201
-21% -$244K 0.07% 137
2015
Q1
$1.09M Sell
14,899
-41,001
-73% -$2.92M 0.12% 129
2014
Q4
$3.88M Sell
55,900
-50,290
-47% -$3.39M 0.42% 45
2014
Q3
$6.92M Buy
106,190
+92,687
+686% +$5.87M 0.18% 144
2014
Q2
$836K Buy
+13,503
New +$806K 0.09% 135

Other funds holding LLY

Lombard Odier Asset Management (Switzerland)'s LLY Position: Q1 2026 in Review

Lombard Odier Asset Management (Switzerland) increased its Eli Lilly (LLY) stake by 14% in Q1 2026, buying an estimated $4.48M and bringing the position to 36,080 shares worth $33.2M. The position accounts for 1.26% of the portfolio, ranked #11.

Lombard Odier Asset Management (Switzerland) first reported a position in LLY in Q2 2014 and has held it in 42 quarters since. The position peaked at $34M in Q4 2025. 4,358 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lombard Odier Asset Management (Switzerland) held 36,080 shares of Eli Lilly worth $33.2M as of Q1 2026.
  • Lombard Odier Asset Management (Switzerland) bought 4,423 Eli Lilly shares in Q1 2026, an estimated $4.48M.
  • Eli Lilly made up 1.26% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q1 2026, its #11 holding.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Eli Lilly in Q2 2014 and has held it in 42 quarters since.
  • Lombard Odier Asset Management (Switzerland)'s Eli Lilly position peaked at $34M in Q4 2025.
  • 4,358 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2026, filed 15 May 2026.